GL1X · GenesisL1 explorer

MolNFT v1 · #148329 · protein

IRAK4 in complex with inhibitor

6F3I · Interleukin-1 receptor-associated kinase 4: “IRAK4 in complex with inhibitor”. X-ray diffraction, 2 ligands (CKN, SO4), 4 pockets (best druggability 0.73). MolNFT v1 #148329 on GenesisL1: 3D structure, binding sites and pockets in…

PDB
6F3I
Type
protein
Length
541 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Interleukin-1 receptor-associated kinase 4
EC
2.7.11.1
UniProt
Q9NWZ3
Ligands
CKN, SO4
Pockets
4 · best druggability 0.73

Structure

x-ray diffraction · 2 distinct chains · 42% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AInterleukin-1 receptor-associated kinase 4 (EC 2.7.11.1)protein26042% helix, 13% strandQ9NWZ3
BInterleukin-1 receptor-associated kinase 4 (EC 2.7.11.1)protein28142% helix, 15% strandQ9NWZ3

Ligands and binding sites

  • CKN · (3~{R})-3-[4-[[4-(4-ethanoylpiperazin-1-yl) cyclohexyl]amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]butanamide · ligand · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17290.730.7950empty
24730.710.8161CKN
33360.650.8038CKN
4680.310.7513empty

Interfaces

1 interface between chains.

  • A–B · 646 Ų buried · 6 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 modified (phosphorylation).

Compared structures

  • 6F3I · IRAK4 IN COMPLEX WITH inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.